clinical , prophylactic and bacteriological effects of czx were evaluated and adverse reactions and effects on laboratory test values due to this drug were studied in 22 neonates and low birth weight infants ( 0-76 day old ) consisting of 16 cases with various bacterial infections including presumptive cases of bacterial infections and 6 cases with prophylactic administration against infectious diseases .
C0004623
bacterial infections
C0009450
infectious diseases